40 related articles for article (PubMed ID: 30073742)
1. Programmable co-delivery of the immune checkpoint inhibitor NLG919 and chemotherapeutic doxorubicin via a redox-responsive immunostimulatory polymeric prodrug carrier.
Sun JJ; Chen YC; Huang YX; Zhao WC; Liu YH; Venkataramanan R; Lu BF; Li S
Acta Pharmacol Sin; 2017 Jun; 38(6):823-834. PubMed ID: 28504251
[TBL] [Abstract][Full Text] [Related]
2. Chitosan oligosaccharide-functionalized nano-prodrug for cascade chemotherapy through oxidative stress amplification.
Cui L; Xu Q; Lou W; Wang Y; Xi X; Chen Y; Sun M; Wang Z; Zhang P; Yang S; Zhang L; Qu L
Int J Biol Macromol; 2024 May; 268(Pt 2):131641. PubMed ID: 38641277
[TBL] [Abstract][Full Text] [Related]
3. Redox-Responsive Self-Assembled Chain-Shattering Polymeric Therapeutics.
Cai K; Yen J; Yin Q; Liu Y; Song Z; Lezmi S; Zhang Y; Yang X; Helferich WG; Cheng J
Biomater Sci; 2015 Jul; 3(7):1061-5. PubMed ID: 26146551
[TBL] [Abstract][Full Text] [Related]
4. Self-Assembly of pH-Labile Polymer Nanoparticles for Paclitaxel Prodrug Delivery: Formulation, Characterization, and Evaluation.
Levit SL; Gade NR; Roper TD; Yang H; Tang C
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291475
[TBL] [Abstract][Full Text] [Related]
5. Anticancer nano-prodrugs with drug release triggered by intracellular dissolution and hydrogen peroxide response.
Shibata A; Koseki Y; Tanita K; Kitajima S; Oka K; Maruoka K; Suzuki R; Thi Ngoc Dao A; Kasai H
Chem Commun (Camb); 2024 Jun; 60(50):6427-6430. PubMed ID: 38829169
[TBL] [Abstract][Full Text] [Related]
6. Disulfide/α-Amide-Bridged Doxorubicin Dimeric Prodrug: Effect of Aggregation Structures on pH/GSH Dual-Triggered Drug Release.
Yang C; Liu P
Langmuir; 2024 May; 40(21):11098-11105. PubMed ID: 38739904
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of a Multifunctional Glyco-Block Copolymer through Reversible Addition-Fragmentation Chain Transfer Polymerization and Click Chemistry for Enzyme and Drug Loading into MDA-MB-231 Cells.
Wu TC; Lai CL; Sivakumar G; Huang YH; Lai CH
ACS Appl Mater Interfaces; 2023 Dec; 15(51):59746-59759. PubMed ID: 38108280
[TBL] [Abstract][Full Text] [Related]
8. Diselenide-Bridged Doxorubicin Dimeric Prodrug: Synthesis and Redox-Triggered Drug Release.
Hu Y; Liu P
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675530
[TBL] [Abstract][Full Text] [Related]
9. Hydrophobicity-Adaptive Polymers Trigger Fission of Tumor-Cell-Derived Microparticles for Enhanced Anticancer Drug Delivery.
Liu H; Xu S; Yong T; Wei Z; Bie N; Zhang X; Li X; Li J; Li S; Wang S; Zhao Y; Yang X; Gan L
Adv Mater; 2023 Nov; 35(45):e2211980. PubMed ID: 37755231
[TBL] [Abstract][Full Text] [Related]
10. Trisulfide bond-mediated doxorubicin dimeric prodrug nanoassemblies with high drug loading, high self-assembly stability, and high tumor selectivity.
Yang Y; Sun B; Zuo S; Li X; Zhou S; Li L; Luo C; Liu H; Cheng M; Wang Y; Wang S; He Z; Sun J
Sci Adv; 2020 Nov; 6(45):. PubMed ID: 33148644
[TBL] [Abstract][Full Text] [Related]
11. Stimuli-sensitive polymer prodrug nanocarriers by reversible-deactivation radical polymerization.
Guerassimoff L; Ferrere M; Bossion A; Nicolas J
Chem Soc Rev; 2024 Jun; 53(12):6511-6567. PubMed ID: 38775004
[TBL] [Abstract][Full Text] [Related]
12. Switchable Fluorescence of Doxorubicin for Label-Free Imaging of Bioorthogonal Drug Release.
Uyar TB; Wu K; He M; Khan I; Royzen M; Yigit MV
ChemMedChem; 2020 Jun; 15(11):988-994. PubMed ID: 32216081
[TBL] [Abstract][Full Text] [Related]
13. Molecularly Imprinted Polymer-Based Smart Prodrug Delivery System for Specific Targeting, Prolonged Retention, and Tumor Microenvironment-Triggered Release.
Gu Z; Dong Y; Xu S; Wang L; Liu Z
Angew Chem Int Ed Engl; 2021 Feb; 60(5):2663-2667. PubMed ID: 33078504
[TBL] [Abstract][Full Text] [Related]
14. Dynamic Release from Acetalated Dextran Nanoparticles for Precision Therapy of Inflammation.
Erensoy G; Råberg L; von Mentzer U; Menges LD; Bardhi E; Hultgård Ekwall AK; Stubelius A
ACS Appl Bio Mater; 2024 Jun; 7(6):3810-3820. PubMed ID: 38795048
[TBL] [Abstract][Full Text] [Related]
15. Experimental evidence of good efficacy and reduced toxicity with peptide-doxorubicin to treat gastric cancer.
Zhang J; Yuan JP; Wang Q; Shao LH; Liu SP; Firestone RA; Hong YP; Li JG; Xin YC; Li Y
Oncotarget; 2018 Jan; 9(2):1957-1968. PubMed ID: 29416744
[TBL] [Abstract][Full Text] [Related]
16. Photoswitchable particles for on-demand degradation and triggered release.
Park TH; Eyster TW; Lumley JM; Hwang S; Lee KJ; Misra A; Rahmani S; Lahann J
Small; 2013 Sep; 9(18):3051-7. PubMed ID: 23606461
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticulation of Prodrug into Medicines for Cancer Therapy.
Zhang Y; Cui H; Zhang R; Zhang H; Huang W
Adv Sci (Weinh); 2021 Sep; 8(18):e2101454. PubMed ID: 34323373
[TBL] [Abstract][Full Text] [Related]
18. Molecular Design and Controlled Self-Assembly of Copolymers as Core-Shell-Corona Nanoparticles for Smarter Tumor Treatment.
Liu P
Langmuir; 2024 Jan; 40(2):1143-1149. PubMed ID: 38166440
[TBL] [Abstract][Full Text] [Related]
19. pH/Reduction Dual-Triggered Degradable Poly(doxorubicin) Prodrug Nanoparticles for Leakage-Free Tumor-Specific Self-Delivery.
Li J; Liu P
Macromol Rapid Commun; 2018 Sep; 39(18):e1800381. PubMed ID: 30073742
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
